In transgenic APP/PS1 mice, progressive degeneration of pericytes was found to accelerate Alzheimer-like neurodegeneration [11], suggesting that counteracting pericyte loss may have therapeutic benefit in modifying AD progression. Here, APP is linked to Alzheimer disease.